Page 2 - அதிகப்படியான பங்குகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அதிகப்படியான பங்குகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அதிகப்படியான பங்குகள் Today - Breaking & Trending Today

Investegate |FireAngel SafetyTech Announcements | FireAngel SafetyTech: Replacement


 
The following amendment has been made to the
Placings and Open Offer announcement released on 30 April 2021 at 7.00 a.m. under RNS No 1510X.
The date underlined in the following sentence has been changed from June 2022 to 2024 within the body of the announcement:
Thereafter, once production of the next generation smoke alarm has commenced, a royalty fee per product will be payable to the Company as the manufacturing partner, with a multi-million volume fee agreed for the initial thirty months, with a minimum royalty fee commitment of €3.0 million (estimated to exceed £1.0 million by 2024).
All other details remain unchanged.
The full amended text is shown below. ....

United States , United Kingdom , South Africa , Northern Ireland , City Of , New Zealand , Channel Islands , Western Australia , London Borough Of Ealing , Republic Of South Africa , Canaccord Genuity , Fireangel Predict , John Conoley , Tom Griffiths David Coaten , Rick Thompson Alex , Zoe Fox , Kate Hoare Laura Stewart , Neville Registrars , United Kingdom Financial Conduct Authority , Firm Placing Of The , While The Company , Commission Delegated Directive , Principal Terms Of The Firm , Canaccord Genuity Group Inc , Firm Placing Or Conditional , London Stock Exchange ,

Diurnal (AIM:DNL) | RNS | Diurnal Group PLC - Proposed Placing, Subscription and Open Offer


REPUBLIC OF SOUTH AFRICA OR
JAPAN. NEITHER THIS ANNOUNCEMENT NOR ANYTHING CONTAINED HEREIN SHALL FORM THE BASIS OF, OR BE RELIED UPON IN CONNECTION WITH, ANY OFFER OR COMMITMENT WHATSOEVER IN ANY JURISDICTION.
 
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU AS IT FORMS PART OF THE LAW OF
ENGLAND AND
WALES BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. IN ADDITION, MARKET SOUNDINGS WERE TAKEN IN RESPECT OF THE MATTERS CONTAINED IN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF SUCH INSIDE INFORMATION. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION. ....

United States , District Of Columbia , United Kingdom , South Africa , Northern Ireland , City Of , New Zealand , Republic Of South Africa , Great Britain , Europe Alkindi , Foster Mitchell , Chiesi Farmaceutici , Emma Earl , Sam Williams , Medison Pharma , John Goddard , Freddy Crossley , Martin Whitaker , Richard Bungay , Panmure Gordon , Simon Conway , Panmure Gordons , Rupert Dearden , Effrx Pharmaceuticals For Alkindi , Company To Panmure Gordon , Consilient Health For The Nordic ,